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right ª 2016, Medical AssociationAbstract
Chronic inflammation is known to be associated with visceral obesity and insulin resis-
tance which are characterized by altered levels of production of pro- and anti-
inflammatory adipokines. The dysregulation of the production of inflammatory adipokines
and their functions in obese individuals leads to a state of chronic low-grade inflammation
and may promote obesity-linked metabolic disorders and cardiovascular diseases such as
insulin resistance, metabolic syndrome, and atherosclerosis. Electroacupuncture (EA)
was tested to see if there was a difference in its effect on pro- and anti-inflammatory adi-
pokine levels in the blood serum and the white adipose tissue of obese Zucker fatty rats
and high-fat diet-induced obese Long Evans rats. In the two rat models of obesity, on Day
12 of treatment, repeated applications of EA were seen to have had a significant differ-
ential effect for serum tumor necrosis factor-a, adiponectin, the adiponectin:leptin ra-
tio, and blood glucose. For the adipose tissue, there was a differential effect for
adiponectin that was on the borderline of significance. To explore these changes further
and how they might affect insulin resistance would require a modification to the research
design to use larger group sizes for the two models or to give a greater number of EA
treatments.tributed under the terms of the Creative Commons Attribution Non-Commercial License (http://
4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any
properly cited.
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Obesity is a major public health concern and is associated
with an increased risk of chronic diseases including type 2
diabetes, cardiovascular disease, cancer, decreased
health-related quality of life and overall life expectancy,
and increased health care costs [1]. It results from a com-
plex interplay of many genetic and environmental factors.
Several studies have shown that the detrimental influ-
ence of abdominal obesity on metabolic processes is
mediated by the intra-abdominal fat depot [2,3]. The
visceral fat depot correlated with glucose intolerance in
the presence of hyperinsulinemia during an oral glucose
tolerance test, suggesting an insulin-resistant state in
human obesity [4]. Insulin resistance and hyperinsulinemia
are often associated with obesity, and the ability of obesity
to engender insulin resistance is the major basis for the
association of obesity with type 2 diabetes mellitus.
The accumulation of fat mass during the development of
obesity is characterized by adipocyte hyperplasia and hy-
pertrophy. The prevalence of hypertrophied adipocytes in
adipose tissue results in a reduction in blood flow with sub-
sequent hypoxia and macrophage infiltration, and increased
production of proinflammatory adipokines [3e7]. Many of the
proinflammatory cytokines are secreted by the adipocytes,
whereas others are predominantly derived from adipose
tissue-infiltrated macrophages. The dysregulation of pro- and
anti-inflammatory adipokine production and their functions
in obese individuals leads to a state of chronic low-grade
inflammation and may promote obesity-linked metabolic
disorders and cardiovascular diseases such as insulin resis-
tance, metabolic syndrome, and atherosclerosis [8]. Obesity-
associated inflammation may impair insulin action systemi-
cally through increasing free fatty acids (FFA) or proin-
flammatory adipokines [e.g., leptin, tumor necrosis factor-a
(TNF-a)] in circulation as both are able to target insulin re-
ceptor substrate proteins and modify the metabolic and
mitotic effects of insulin leading to insulin resistance [9e13].
This paper examines whether the effect of electro-
acupuncture (EA) is different in two rat models of obesity
by comparing the levels of pro- and anti-inflammatory
adipokines in the two models with and without EA treat-
ment. The two models used were the obese Zucker fatty
rats and diet-induced obese Long Evans rats. Obesity de-
velops in the former as a result of a genetic mutation in the
leptin receptor, while in the latter it develops as a result of
high dietary fat intake. The obese Zucker fatty rat has been
used as a model of metabolic syndrome and develops hy-
perphagia, dyslipidemia, hyperleptinemia, hyper-
insulinemia, central adiposity, hypertension, insulin
resistance, and diabetes [14,15], all being risk factors
involved in metabolic syndrome [16]. Homeostasis model
assessment of insulin resistance was significantly greater
for obese Zucker fatty rats than lean Zucker fatty rats [17].
Obesity induced in Long Evans rats by a high-fat diet (HFD)
was reported to be associated with hyperleptinemia and
insulin resistance [18,19]. Li et al [20] have shown that HFD-
induced obese Long Evans rats at 25 weeks of age had
significantly higher fasting plasma total cholesterol, tri-
glyceride, insulin, leptin, and adiponectin levels when
compared with lean animals of that age. Fasting plasmaglucose was not significantly different to the lean animals.
In oral glucose tolerance test at 21 weeks of age, both
glucose and insulin levels were significantly higher after
overnight fasting and at every time point after the oral
glucose challenge in the diet-induced obese rats indicating
impaired insulin sensitivity. There is increasing clinical ev-
idence for the effectiveness of acupuncture as a treatment
of insulin resistance [21], and possible changes in the
circulating levels of pro- and anti-inflammatory adipokines
by EA intervention could lead to a decrease in insulin
resistance by affecting insulin sensitivity.
2. Materials and methods
2.1. Animals
Male Zucker fa/fa rats 12e14 weeks of age and male Long
Evans rats at 3 weeks of age were obtained from a breeding
colony maintained at the Taieri Animal Station and deliv-
ered to the Hercus Taieri Research Unit, University of
Otago, Dunedin, New Zealand. The obese Zucker rats were
fed standard rat chow (Specialty Feeds irradiated rat and
mouse cubes, 4.8% fat, 20% protein, amino acids, vitamins
and minerals, 3.34 kcal/g; Specialty Feeds, Glen Forest,
Western Australia), housed in individual cages and accli-
matized to the new environment for 1 week. The just-
weaned Long Evans rats were fed with a HFD (Specialty
Feeds SF 03-020, 23% fat, 20% protein, 42% sucrose, amino
acids, vitamins and minerals, 4.78 kcal/g; Specialty Feeds)
for 9 weeks immediately following delivery and group
housed (5 rats/cage). All the rats were given free access to
food and water in a room with 12-hour/12-hour light/dark
cycle at a constant temperature. The HFD-fed Long Evans
rats were weighed on the day immediately prior to the start
of the study and those with a weight equal to or greater
than the mean weight plus two standard deviations of
normal rat chow-fed male Long Evans rats of the same age
were selected for the study and placed in individual cages.
These rats were designated as obese Long Evans rats. All
animals were deprived of food at 3:00 PM on the day prior to
the experiment to ensure an overnight fast of at least 17
hours. This study was approved by the University of Otago
Animal Ethics Committee.
2.2. Treatment of animals
2.2.1. Anesthesia and EA
This involved lightly anesthetizing the animals with 1%
halothane in a 3:1 mixture of nitrous oxide:oxygen 1.2 L/
min. Blood glucose (BG) was measured with a hand-held
glucometer (Accu-Chek Advantage, Roche, Roche Di-
agnostics NZ Ltd., Mt Wellington, Auckland, New Zealand)
after needle pricking the lateral saphenous vein of one of
the hind limbs at 10 minutes and 20 minutes following
anesthesia. The obese Zucker rats in Group 1 (n Z 5) were
treated with EA applied at the Zhongwan (conception
vessel; CV12) and Guanyuan (CV4) acupoints on alternate
weekdays (Monday/Wednesday/Friday) over 2 weeks giving
a total of six applications of EA; those in Group 2 (n Z 7)
were not treated with EA and served as controls [22].
Similarly the obese Long Evans rats in Group 3 (nZ 7) were
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nyuan (CV4) acupoints on alternate weekdays (Monday/
Wednesday/Friday) over 2 weeks, while those in Group 4
(n Z 7) served as controls [23]. Controls were handled in
the same way as EA-treated animals.
Sterile acupuncture needles (Seirin Corporation, Shi-
zuoka, Japan; 0.25 mm  15 mm) were inserted into the
muscle layer at the chosen acupoints to a depth of 4 mm. EA
was carried out for 30 minutes at a frequency 10 Hz, pulse
width 200 mS, and intensity 10e15 mA using Hans E600 EA
unit (Han’s Healthronics, Likon, Taipei, Taiwan). The posi-
tive and negative charges were connected to the Zhongwan
and Guanyuan acupoints, respectively. On each day at the
completion of treatment, BG was measured again (i.e., at
50 minutes) and the weights of the animals measured.
2.2.2. Collection of blood serum and white adipose tissue
At the completion of the study on Day 12, the rats were given
sodium pentobarbitone (60 mg/mL in sterile saline, 0.4 mL
intraperitoneal injection). Blood was collected by cardiac
puncture into tubes and white adipose tissue harvested from
the pelvic region and frozen immediately in liquid nitrogen.
The blood samples were centrifuged (1,500g for 10 minutes)
and the sera stored at 20C and adipose tissue samples
stored at 80C until assays for adiponectin, leptin, TNF-a,
interleukin-10 (IL-10), and insulin were performed.
2.3. Homogenization of white adipose tissue
Adipose tissue (0.200 g) was homogenized in radio-
immunoprecipitation assay (RIPA) buffer (0.60 mL) using a
Qiagen tissue lyser II (Venlo, Netherlands; Program P5, 20
Hz, 2 minutes). The radioimmunoprecipitation assay buffer
(0.625% Igepal CA-630, 0.625% sodium deoxycholate,
6.25mM sodium phosphate, and 1mM EDTA at pH 7.4) con-
tained 10 mg/mL of protease inhibitor cocktail (Product
P8340, Sigma Aldrich, St. Louis, MO, USA). Homogenates
were centrifuged at 4C (12,000g for 5 minutes). An opening
was made in the fat layer and the infranatants were
collected and stored at 20C [24].
2.4. Outcomes measured in blood sera and adipose
tissue homogenates
The rat blood sera collected at the end of the study were
assayed for insulin, adiponectin, leptin, TNF-a, and IL-10.
The white adipose tissue homogenates were assayed for
adiponectin, leptin, TNF-a, and IL-10. Insulin and the four
mentioned adipokines were measured using rat enzyme-
linked immunosorbent assay kits (Millipore, Abacus ALS,
Auckland, New Zealand). The product numbers for the Milli-
pore enzyme-linked immunosorbent assay kits were EZRADP-
62K (rat adiponectin), EZRL-83K (rat leptin), IBBE45311 (IBL
rIL-10), EZRTNFA (rat TNF-a), and EZRMI-13K (rat/mouse in-
sulin). TheassayswereperformedbyNewZealandVeterinary
Pathology, Palmerston North, New Zealand.
2.5. Statistical analysis
Means and standard deviations of BG at 20 minutes and
change in BG over a 30 minute interval for Groups 1e4 onDay 1, Day 3, Day 5, Day 8, Day 10, and Day 12 were
compared using analysis of variance and when a significant
p value was found, Duncan’s post hoc test was performed.
Significance was taken to be at the level of p < 0.05.
Descriptive statistics (means and standard deviations)
were presented for each outcome measured in the blood
serum and adipose tissue by animal type and EA interven-
tion combination. For each outcome, a regression model
was used to allow modeling a two-way factorial design with
interaction. Where there was evidence that model as-
sumptions were not satisfied (including evidence for non-
normality from inspecting residual histograms and con-
ducting formal tests of skew and kurtosis and evidence for
heteroscedasticity from Levene’s test for equality of vari-
ance), robust standard errors (from HubereWhite sandwich
estimators) were used. This was the case for all outcomes
aside from IL-10 and TNF-a for the blood sera. Overall
differences between all four groups were assessed, with
pairwise differences presented where the overall test was
statistically significant, along with a test for an interaction
between the intervention and animal type. Stata 13.1
(StataCorp LP, College Station, TX, USA) was used for all
analyses with two-sided p < 0.05 considered statistically
significant in each case.
The “overall difference” tests the four values for a
measured outcome and if a p value was < 0.05 then there
was a significant difference between at least two of the
values. With the exception of one outcome all the p values
were significant for the sera, and also for the adipose tis-
sue, and justified testing for a differential effect of EA.
The “p value for interaction” tests the difference be-
tween the differences of EA and control values for the two
models. If a p value was < 0.05 then there was a differ-
ential effect of EA between the two models. Even with the
small group sizes used, the statistical testing indicated that
the effect of EA was different between the two models for
three of the measured adipokine outcomes in the sera.
3. Results
3.1. For control (i.e., untreated) animals
Mean values of BG at 20 minutes for Group 2 of obese
Zucker rats were significantly greater than for Group 4 of
obese Long Evans rats on Day 1, Day 3, Day 5, Day 8, Day 10,
and Day 12 (Table 1). There was no significant difference in
mean change in BG over a 30-minute interval between
Groups 2 and 4 on Day 1, Day 3, Day 5, Day 8, Day 10, and
Day 12 (Table 2). The BG values at 20 minutes for obese
Long Evans rats in Group 4 did not differ significantly from
those of lean Long Evans rats except on Day 3 and Day 5
when a lower value was found for the obese Long Evans rats
[18], thus confirming that the obese Long Evans rats were
not hyperglycemic. The highest BG value of 7.96 mmol/L
for obese Zucker rats in Group 2 occurred on Day 1 and
indicated that these rats were also not hyperglycemic.
For the assays of blood sera on Day 12, the mean levels
of leptin, TNF-a, and insulin were significantly greater for
Group 2 than Group 4. There were no significant differences
in mean levels of adiponectin and IL-10 between Groups 2
and 4. The mean adiponectin:leptin ratio and IL-10:TNF-a
Table 1 Baseline blood glucose (mmol/L) at 20 minutes.*
Obese Zucker rats Obese Long Evans rats
Group 1 EA Group 2 Group 3 EA Group 4
D 1 7.92 (1.19)a 7.96 (1.44)a 5.73 (0.81)b 5.83 (0.60)b
D 3 5.42 (0.91)c 5.74 (1.36)c 3.90 (0.24)d 3.87 (0.37)d
D 5 4.94 (0.47)e 4.84 (1.22)e 3.94 (0.29)f 3.76 (0.35)f
D 8 6.08 (0.78)g 5.10 (0.84)h 4.01 (0.40)j 4.11 (0.44)j
D 10 7.04 (1.16)k 5.84 (0.83)l 4.10 (0.22)m 4.13 (0.39)m
D 12 5.54 (0.95)n 5.40 (0.42)n 4.41 (0.44)p 4.41 (0.49)p
Data presented as mean (standard deviation).
* Data tested for each group with analysis of variance and
Duncan’s test with significance taken to be at the level
p < 0.05. For each day, values with different superscripts across
individual rows are significantly different.
EA Z electroacupuncture.
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(Table 3).
From the assays of white adipose tissue homogenates on
Day 12, the mean level of leptin was significantly greater
for Group 2 compared with Group 4, whereas the mean
levels of adiponectin and IL-10 were significantly lower for
Group 2 than Group 4. No significant difference was found
in mean TNF-a levels between Groups 2 and 4. The mean
adiponectin:leptin ratio and IL-10:TNF-a ratio were signif-
icantly lower for Group 2 than Group 4 (Table 4).
3.2. For EA-treated animals
Mean values of BG at 20 minutes were significantly higher
for Group 1 of obese Zucker rats compared with Group 3 of
obese Long Evans rats on Day 1, Day 3, Day 5, Day 8, Day 10,
and Day 12 (Table 1). No significant difference in mean
values of change in BG over a 30-minute interval were
found between Groups 1 and 3 on Day 1, Day 3, and Day 8,
but significantly greater values were obtained for Group 1
compared with Group 3 on Day 5, Day 10, and Day 12. For
Group 1 the mean BG values increased over 30 minutes on
each study day, whereas for Group 3 the mean BG values
decreased over 30 minutes on all of the days (Table 2).Table 2 Change in blood glucose (mmol/L) measured at
50 minutes over a 30-minute interval.*
Obese Zucker rats Obese Long Evans rats
Group 1 EA Group 2 Group 3 EA Group 4
D 1 0.62 (1.34) 0.32 (0.45) 0.20 (0.51) 0.31 (0.47)
D 3 0.48 (1.71) 0.60 (0.16) 0.30 (0.24) 0.10 (0.30)
D 5 1.02 (1.09)a 0.18 (0.26)b 0.41 (0.12)b 0.09 (0.17)b
D 8 0.22 (0.41) 0.04 (0.61) 0.06 (0.23) 0.16 (0.33)
D 10 2.54 (4.00)c 0.22 (0.66)d 0.19 (0.32)d 0.13 (0.46)d
D 12 1.04 (0.35)e 0.04 (0.54)f 0.16 (0.17)f 0.03 (0.46)f
Data presented as mean (standard deviation).
* Data tested for each group with analysis of variance and
Duncan’s test with significance taken to be at the level
p < 0.05. For each day, values with different superscripts across
individual rows are significantly different.
EA Z electroacupuncture.From the assays of blood sera on Day 12, the mean levels
of leptin and insulin were significantly higher for Group 1
compared with Group 3, whereas there was no significant
difference in mean TNF-a levels between Groups 1 and 3.
The mean levels of adiponectin and IL-10 were significantly
lower for Group 1 than Group 3. The mean adipo-
nectin:leptin ratio and IL-10:TNF-a ratio were also signifi-
cantly lower for Group 1 than Group 3 (Table 3).
For the assays of the white adipose tissue homogenates
on Day 12, the mean leptin level was significantly greater
for Group 1 compared with Group 3, while the mean levels
of adiponectin and IL-10 were significantly lower for Group
1 compared with Group 3. No significant difference was
found in the mean TNF-a level of Groups 1 and 3. The mean
adiponectin:leptin ratio and IL-10:TNF-a ratio were signif-
icantly lower for Group 1 than Group 3 (Table 4).
3.3. EA-treated animals versus control animals
Mean values of BG at 20 minutes for EA-treated and control
obese Zucker rats did not differ significantly on Day 1, Day
3, Day 5, and Day 12, but were significantly greater for EA-
treated animals on Day 8 and Day 10. No significant dif-
ference in mean values of change in BG over a 30-minute
interval were found between EA-treated and control obese
Zucker rats on Day 1, Day 3, and Day 8, but a significantly
greater (all positive) value was observed for EA-treated
animals on Day 5, Day 10, and Day 12. For obese Long Evans
rats, there were no significant differences in mean values
of BG at 20 minutes or change in BG over a 30-minute in-
terval for EA-treated and control animals.
For the assays of blood sera on Day 12, the mean levels of
adiponectin, leptin, adiponectin:leptin ratio, IL-10, IL-
10:TNF-a ratio, and insulin did not differ significantly be-
tween EA-treated and control obese Zucker rats, whereas
that for TNF-a was significantly lower for EA-treated
compared with control animals. For obese Long Evans rats,
therewasnodifference in themeanvaluesof adiponectin, IL-
10, TNF-a, IL-10:TNF-a ratio, and insulin between EA-treated
and control animals, but that for leptin was significantly
increased and for adiponectin:leptin ratio significantly
decreased for EA-treated compared with control animals.
From the assays of the white adipose tissue homogenates
on Day 12, there were no significant differences in mean
values between EA-treated and control obese Zucker rats.
Also no significant differences in mean values were found
between EA-treated and control obese Long Evans rats.
3.4. Interaction between EA intervention and
animal model
The effect of EA was different in the two obese rat models
with there being a significant interaction in serum adipo-
nectin, adiponectin:leptin ratio, and TNF-a for obese Zucker
rats compared with obese Long Evans rats. For example, in
Zucker rats there was a nonsignificant difference in adipo-
nectin in EA-treated rats which was less than the control,
and for Long Evans rats there was a nonsignificant difference
in EA-treated rats which was greater than the control, but
the difference of these differences was significant
(p Z 0.024). For adiponectin:leptin ratio, for Zucker rats
Table 3 Measured outcomes in blood sera on Day 12.*,y
Outcome Obese Zucker Obese Long Evans p for overall
difference
p for
interactionGroup 1 EA Group 2 Group 3 EA Group 4
Adiponectin (mg/mL) 15.28 (6.82)a 21.72 (2.55)ab 25.99 (3.68)c 22.74 (2.07)bc 0.035 0.024
Leptin (ng/mL) 66.16 (8.72)a 63.23 (4.93)a 5.62 (1.71) 3.85 (0.72) <0.001 0.814
Adiponectin:leptin (103) 0.24 (0.13)a 0.33 (0.03)a 4.72 (1.00) 6.01 (0.82) <0.001 0.038
IL-10 (pg/mL) 12.91 (5.10)a 20.15 (7.57)ab 27.86 (8.32)b 23.90 (10.96)ab 0.082 0.167
TNF-a (pg/mL) 3.46 (1.78)a 18.89 (1.48) 3.43 (1.44)a 3.26 (1.15)a <0.001 <0.001
IL-10:TNF-a 2.66 (0.93) 1.00 (0.49) 9.01 (3.79)a 6.93 (2.18)a <0.001 0.821
Insulin (ng/mL) 13.63 (1.91)b 12.42 (3.24)b 3.13 (1.31)a 2.87 (1.02)a <0.001 0.628
Data presented as mean (standard deviation).
* A regression model was used to allow modeling a two-way factorial design with interaction. Where there was evidence that model
assumptions were not satisfied, robust standard errors were used. Stata 13.1 was used for all analyses with two-sided p < 0.05
considered statistically significant in each case.
y Stata lettering system identifies which particular pairs of groups are different, so columns sharing a letter showed no evidence of being
different and columns not sharing a letter (including columns where both are “blank”) showed evidence of being different; “blanks” are
different to all other values including other “blanks.”
EA Z electroacupuncture; IL Z interleukin; TNF Z tumor necrosis factor.
Table 4 Measured outcomes in adipose tissue on Day 12.*,y
Outcome Obese Zucker Obese Long Evans p for overall
difference
p for
interactionGroup 1 EA Group 2 Group 3 EA Group 4
Adiponectin (mg/mL) 13.35 (6.35)a 7.35 (3.38)a 20.19 (2.23)b 20.02 (2.06)b <0.001 0.098
Leptin (ng/mL) 48.16 (7.58)b 43.06 (5.23)b 7.65 (1.76)a 6.16 (1.44)a <0.001 0.362
Adiponectin:leptin (103) 0.27 (0.11)a 0.17 (0.07)a 2.79 (0.83)b 3.39 (0.73)b <0.001 0.119
IL-10 (pg/mL) 469.38 (36.66)a 486.70 (63.19)a 597.88 (89.95)b 580.86 (89.80)b 0.005 0.562
TNF-a (pg/mL) 21.13 (3.64)b 17.87 (3.81)ab 17.60 (2.23)ab 16.20 (2.69)a 0.078 0.469
IL-10:TNF-a 22.70 (4.09)a 27.97 (5.73)ab 34.56 (7.47)bc 37.01 (9.67)c 0.015 0.650
Data presented as mean (standard deviation).
* A regression model was used to allow modeling a two-way factorial design with interaction. Where there was evidence that model
assumptions were not satisfied, robust standard errors were used. Stata 13.1 was used for all analyses with two-sided p < 0.05
considered statistically significant in each case.
y Stata lettering system identifies which particular pairs of groups are different, so columns sharing a letter showed no evidence of being
different and columns not sharing a letter (including columns where both are “blank”) showed evidence of being different; “blanks” are
different to all other values including other “blanks.”
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which was less than the control, and for Long Evans rats a
significant difference in EA-treated rats which was less than
the control, with the difference of these differences being
significant (p Z 0.038). With regards to TNF-a, for Zucker
rats there was a significant difference in EA-treated rats
which was less than the control, and a nonsignificant dif-
ference EA-treated rats which was greater than the control
for Long Evans rats, with the difference of these differences
being significant (p < 0.001). A similar statistical analysis of
mean BG values on Day 12 gave a significant difference be-
tween the two models with and without EA but not within
the models for EA-treated versus control (pZ 0.004).
For the adipose tissue, no significant interactions were
found although for adiponectin there was a nonsignificant
difference in EA-treated rats greater than the control for
Zucker rats, and a small nonsignificant difference in EA-
treated rats greater than the control for Long Evans rats,
with the difference of these differences being on the
borderline of significance (p Z 0.098).4. Discussion
Insulin resistance can be defined as decreased sensitivity or
decreased responsiveness, or by combinations of the two,
to the metabolic actions of normal concentrations of insulin
such as insulin-mediated glucose disposal [25]. Obesity is
the most common cause of insulin resistance and at least
three candidate molecules have been implicated in the
development of insulin resistance due to obesity [26].
Circulating lipids such as FFA, which are increased in
obesity, inhibit glucose uptake and use in muscle [27]. TNF-
a inhibits glucose uptake in muscle, and causes phosphor-
ylation of insulin receptor substrate-1 which inhibits insulin
signal transduction [28] or downregulation of glucose
transporter type 4 [29]. Increased level of leptin which is
associated with obesity may cause insulin resistance [30].
Adiponectin and IL-10 are both anti-inflammatory cytokines
and act to increase insulin sensitivity.
The present study has examined whether the effect of
EA is different in two animal models of obesity, the Zucker
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study measured levels of BG and important adipokines that
contribute to a pro-/anti-inflammatory cytokine imbalance
in obesity and a possible insulin-resistant state. Insulin
resistance is closely associated with obesity, type 2 dia-
betes mellitus, hypertension, and metabolic syndrome, and
is a risk factor for serious diseases such as cardiovascular
disease. EA has been shown to be effective in improving
insulin sensitivity and lowering BG in diabetic rodents and
obese humans [31e34].
The male obese Zucker rats were at 15 weeks of age, and
the male Long Evans rats had been fed HFD from weaning at
3 weeks of age and those at 12 weeks of age with a body
weight two standard deviations greater than that of male
lean Long Evans rats were selected for the study. While
both of these animal models were normoglycemic, the
mean baseline BG for controls (no EA, measured at 20 mi-
nutes after inducing anesthesia) was greater for the obese
Zucker rats than the obese Long Evans rats. In addition, the
control obese Zucker rats had a much higher serum leptin,
TNF-a, and insulin than the control obese Long Evans rats,
but with no difference in the serum levels of adiponectin
and IL-10. These findings are consistent with obese Zucker
rats being leptin resistant and insulin resistant. Insulin
resistance is by definition tethered to hyperinsulinemia [35]
and insulin resistance induces hyperleptinemia [36]. As a
consequence of the pro-/anti-inflammatory imbalance
being much greater in the obese Zucker rats than in the
obese Long Evans rats, the obese Zucker rat may be a
better model to test EA as a treatment modality to reverse
the pro-/anti-inflammatory imbalance that contributes to
metabolic dysfunction and insulin resistance in obesity. The
obese Long Evans rats were most likely of lower insulin
resistance than the obese Zucker rats as evidenced by the
low serum leptin and insulin levels and this may be due to
the relatively short period of 9 weeks for feeding the HFD
and the young age of the rats at which this was started. As
previously reported, there was no significant difference in
serum insulin levels between control lean and obese Long
Evans rats [23]. In a study by Posey et al [19], Long Evans
rats 8e10 weeks of age and fed HFD for 7 weeks, in 4 hour-
fasted animals the mean plasma leptin was 22 ng/mL and
insulin 5.0 ng/mL. Also in the study by Woods et al [18],
Long Evans rats 8e11 weeks of age and fed HFD for 10
weeks, the mean plasma leptin was 35 ng/mL and insulin
6.6 ng/mL. These levels are much higher than those for the
obese Long Evans rats in the present study.
Repeated EA treatment at CV12/CV4 acupoints signifi-
cantly increased serum leptin and decreased adipo-
nectin:leptin ratio in obese Long Evans rats, consistent with
these rats not being fully leptin resistant [23], and repeated
EA in obese Zucker rats significantly decreased serum TNF-a
and increased IL-10:TNF-a ratio [22]. The effect of EA
differed for the obese Zucker and obese Long Evans rats
with there being a significant interaction between EA
intervention and animal type for serum adiponectin, adi-
ponectin:leptin ratio, and TNF-a on Day 12. Serum adipo-
nectin was nonsignificantly lower for Zucker EA-treated
versus Zucker control, while it was nonsignificantly greater
for Long Evans EA-treated versus Long Evans control (i.e., in
opposite direction to Zucker rats). Serum adipo-
nectin:leptin ratio was nonsignificantly lower for ZuckerEA-treated versus Zucker control, while it was significantly
lower for Long Evans EA treated versus Long Evans control
(i.e., in the same direction). Serum TNF-a was significantly
lower for Zucker EA-treated versus Zucker control, while it
was nonsignificantly lower for Long Evans EA-treated versus
Long Evans control (i.e., in the same direction).
Acupoints CV4 and CV12 are located on the middle line
of the abdomen, and both belong to the Ren Mai meridian.
The anatomical structure of these two acupoints predomi-
nantly consists of the connective tissues. However, these
two acupoints have different nerve innervations (CV4 is
innervated by T12 while CV12 by T7/8). According to classic
acupuncture theories and clinical reports, CV4 has invigo-
rating effects on the whole body and can regulate the
function of the genitourinary system, whereas CV12 has
regulatory effects on functions of the gastrointestinal sys-
tem [37].
To explore the differential effect of EA further (e.g., on
serum adiponectin, adiponectin:leptin ratio) would require
a modification to the research design and this could be to
use larger group sizes for the two models or to give a
greater number of EA treatments. Also, Woods et al [18]
found that feeding HFD for 10 weeks to Long Evans rats at
10 weeks of age resulted in decreased insulin sensitivity as
shown by insulin tolerance test. This may provide a better
diet-induced rat model of obesity with hyperinsulinemia
and insulin resistance. Furthermore, Li et al [20] found for
Long Evans rats fed HFD from weaning, in oral glucose
tolerance test at 21 weeks of age, both glucose and insulin
levels were significantly higher after overnight fasting and
at every time point after the oral glucose challenge indi-
cating impaired insulin sensitivity. These rats would have
been fed HFD for 18 weeks.
The findings from the statistical comparison of data for
the two rat models of obesity would suggest that the
decrease in serum TNF-a for Zucker EA model may lead to a
decrease in insulin resistance in this model. However, with
there being no significant decrease in circulating insulin and
BG compared with controls, the data would more likely
indicate that EA has not lowered insulin resistance in this
model when applied 3 times/wk over 2 weeks. To test for
an alteration in insulin resistance an insulin tolerance test
would need to be performed in which blood is sampled
before and at timed intervals after an intraperitoneal in-
jection of insulin and BG measured [18]. Previous studies
had shown EA to decrease insulin resistance by lowering
circulating FFA levels in steroid-background rats [38] and
HFD mice [39], and by decreasing circulating TNF-a level
and insulin in HFD rats [40]. In addition, in a study by
Tominaga et al [41] using a hyperinsulinemiceeuglycemic
clamp with HFD-induced obese rats treated with EA at
bilateral ST36, the glucose infusion rate and phospho-5’
AMP-activated protein kinase-a in the EA group were
significantly greater compared with the control group. It
was suggested that insulin resistance was significantly
improved by EA probably by activation of 5’ AMP-activated
protein kinase signaling in skeletal muscle.
In summary, repeated EA treatment at CV12/CV4 acu-
points has been shown to cause alterations in the balance
of pro-/anti-inflammatory adipokines in each of the two rat
models of obesity examined. For obese Zucker rats there
was an increase in the IL-10:TNF-a ratio, while for obese
Electroacupuncture in Two Obese Rat Models 189Long Evans rats the adiponectin:leptin ratio was decreased
by EA. This comparative study has indicated the possibility
of other alterations in the levels of adipokines by EA in the
two models and this could be examined in larger sized
studies. It could also be used to compare the effects of EA
in other models such as obese and lean animals or animals
with different extents of metabolic disturbance.
Disclosure statement
The author declares to have no conflicts of interest and no
financial interests related to thematerial of this manuscript.
Acknowledgments
We wish to thank Mr Andrew Gray (Department of Preven-
tive and Social Medicine, University of Otago) for the sta-
tistical analysis of EA interaction in the two models.
References
[1] Walls HL, Backholer K, Proietto J, McNeill JJ. Obesity and
trends in life expectancy. J Obesity. 2012;2012:107989.
[2] Wajchenberg BL. Subcutaneous and visceral adipose tissue:
their relation to the metabolic syndrome. Endocr Rev. 2000;
21:697e738.
[3] Jensen MD. Role of body fat distribution and the metabolic com-
plications of obesity. J Clin Endocrinol Metab. 2008;93:S57eS63.
[4] Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of
intra-abdominal fat accumulation to the impairment of
glucose and lipid metabolism in human obesity. Metabolism.
1987;36:54e59.
[5] Bourlier V, Zakaroff-Girard A, Miranville A, De Barros S,
Maumus M, Sengenes C, et al. Remodeling phenotype of
human subcutaneous adipose tissue macrophages. Circula-
tion. 2008;117:806e815.
[6] Henegar C, Tordjman J, Achard V, Lacasa D, Cremer I, Guerre-
Millo M, et al. Adipose tissue transcription signature highlights
the pathological relevance of extracellular matrix in human
obesity. Genome Biol. 2008;9:R14.
[7] Queiroz JC, Alonoso-Vale MI, Curi R, Lima FB. Control of adi-
pogenesis by fatty acids. Arq Bras Endocrinol Metabol. 2009;
53:582e594.
[8] Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal re-
lationships between insulin resistance and endothelial
dysfunction: molecular and pathophysiological mechanisms.
Circulation. 2006;113:1888e1904.
[9] Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-
related inflammation and insulin resistance: cells, cytokines,
and chemokines. ISRN Inflamm. 2013;2013:139239.
[10] Nguyen MT, Satoh H, Favelyukis S, Babendure JL, Imamura T,
Sbodio JI, et al. JNK and tumor necrosis factor-alpha mediate
free fatty acid-induced insulin resistance in 3T3-L1 adipo-
cytes. J Biol Chem. 2005;280:35361e35371.
[11] Szanto I, Kahn CR. Selective interaction between leptin and
insulin signaling pathways in a hepatic cell line. Proc Natl
Acad Sci USA. 2000;97:2355e2360.
[12] Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K,
et al. Troglitazone increases the number of small adipocytes
without the change of white adipose tissue mass in obese
Zucker rats. J Clin Invest. 1998;101:1354e1361.
[13] Zimmet PZ, Collins VR, de Courten MP, Hodge AM, Collier GR,
Dowse GK, et al. Is there a relationship between leptin and
insulin sensitivity independent of obesity? A population-basedstudy in the Indian Ocean nation of Mauritius. Int J Obes Relat
Metab Disord. 1998;22:171e177.
[14] Kurtz TW, Morris RC, Pershadsingh HA. The Zucker fatty rat as
a genetic model of obesity and hypertension. Hypertension.
1989;13:896e901.
[15] Bray GA. The Zucker-fatty rat: a review. Fed Proc. 1977;36:
148e153.
[16] Angelova P, Boyadjiev N. A review on the models of obesity
and metabolic syndrome in rats. Trakia J Sciences. 2013;1:
5e12.
[17] Rivera L, Moron R, Sanchez M, Zarzuelo A, Galisteo M. Quer-
cetin ameliorates metabolic syndrome and improves the in-
flammatory status in obese Zucker rats. Obesity. 2008;16:
2081e2087.
[18] Woods SC, Seeley RJ, Rushing PA, D’Alessio D, Tso P. A
controlled high-fat diet induces an obese syndrome in rats. J
Nutr. 2003;133:1081e1087.
[19] Posey KA, Clegg DJ, Printz RL, Byun J, Morton GJ, Viveka-
nandan-Giri A, et al. Hypothalamic proinflammatory lipid
accumulation, inflammation, and insulin resistance in rats fed
a high-fat diet. Am J Physiol Endocrinol Metab. 2009;296:
E1003eE1012.
[20] Li S, Zhang HY, Hu CC, Lawrence F, Gallagher KE,
Surapaneni A, et al. Assessment of diet-induced obese rats as
an obesity model by comparative functional genomics.
Obesity. 2008;16:811e818.
[21] Liang F, Koya D. Acupuncture: is it effective for treatment of
insulin resistance? Diabetes Obes Metab. 2010;12:555e569.
[22] Liaw JJT, Peplow PV. Effect of electroacupuncture on in-
flammatory state in the obese Zucker fatty rat model of
metabolic syndrome. J Acupunct Meridian Stud. 2016;9:
73e79.
[23] Liaw JJT, Peplow PV. Effects of electroacupuncture on pro-
/anti-inflammatory adipokines in serum and adipose tissue in
lean and diet-induced obese rats. J Acupunct Meridian Stud.
2016;9:65e72.
[24] Yamashita AS, Lira FS, Rosa JC, Paulino EC, Brum PC,
Negrao CE, et al. Depot-specific modulation of adipokine
levels in rat adipose tissue by diet-induced obesity: the effect
of aerobic training and energy restriction. Cytokine. 2010;52:
168e174.
[25] Kahn CR. Insulin resistance, insulin insensitivity, and insulin
unresponsiveness: a necessary distinction. Metabolism. 1978;
27:1893e1902.
[26] Taylor SI, Barr V, Reitman M. Does leptin contribute to dia-
betes caused by obesity? Science. 1996;274:1151e1152.
[27] Boden G. Role of fatty acids in the pathogenesis of insulin
resistance and NIDDM. Diabetes. 1997;46:3e10.
[28] Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF,
Spiegelman BM. IRS-1-mediated inhibition of insulin receptor
tyrosine kinase activity in TNF-alpha- and obesity-induced
insulin resistance. Science. 1996;271:665e668.
[29] Stephens JM, Pekala PH. Transcriptional repression of the
GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor ne-
crosis factor-alpha. J Biol Chem. 1991;266:21839e21845.
[30] Muller G, Ertl J, Gerl M, Preibisch G. Leptin impairs metabolic
actions of insulin in isolated rat adipocytes. J Biol Chem.
1997;272:10585e10593.
[31] Cabioglu MT, Ergene N. Changes in levels of serum insulin,
C-Peptide and glucose after electroacupuncture and diet
therapy in obese women. Am J Chin Med. 2006;34:
367e376.
[32] Lin RT, Tzeng CY, Lee YC, Chen YI, Hsu TH, Lin JG, et al.
Acupoint-specific, frequency-dependent, and improved insu-
lin sensitivity hypoglycemic effect of electroacupuncture
applied to drug-combined therapy studied by a randomized
control clinical trial. Evid Based Complement Alternat Med.
2014;2014:371475.
190 J.J.T. Liaw, P.V. Peplow[33] Liao HY, Sun MF, Lin JG, Chang SL, Lee YC. Electroacupuncture
plus metformin lowers glucose levels and facilitates insulin
sensitivity by activating MAPK in steroid-induced insulin-
resistant rats. Acupunct Med. 2015;33:388e394.
[34] Tzeng CY, Lee YC, Ho TY, Chen YI, Hsu TH, Lin JG, et al.
Intracellular signaling pathways associated with the glucose-
lowering effect of ST36 electroacupuncture in
streptozotocin-induced diabetic rats. Acupunct Med. 2015;33:
359e399.
[35] Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J. Insulin
resistance and hyperinsulinemia: is hyperinsulinemia the cart
or the horse? Diabetes Care. 2008;31(Suppl. 2):S262eS268.
[36] Hintz KK, Aberle NS, Ren J. Insulin resistance induces hyper-
leptinemia, cardiac contractile dysfunction but not cardiac
leptin resistance in ventricular myocytes. Int J Obes. 2003;27:
1196e1203.
[37] Fang J, Wang X, Liu H, Wang Y, Zhou K, Hong Y, et al. The
limbic-prefrontal network modulated by electroacupunctureat CV4 and CV12. Evid Based Complement Alternat Med. 2012;
2012:515893.
[38] Lin RT, Tzeng CY, Lee YC, Ho WJ, Cheng JT, Lin JG, et al.
Acute effect of electroacupuncture at the Zusanli acupoints
on decreasing insulin resistance as shown by lowering plasma
free fatty acid levels in steroid-background male rats. BMC
Complement Altern Med. 2009;9:26.
[39] Yin J, Kuang J, Chandalia M, Tuvdendorj D, Tumurbaatar B,
Abate N, et al. Hypoglycemic effects and mechanism of
electroacupuncture on insulin resistance. Am J Physiol Regul
Integr Comp Physiol. 2014;307:R332eR339.
[40] Yang H, Li Y, Cheng L, He J. Effect of electroacupuncture and
diet adjusting on insulin resistance in rats with nutrition
obesity. J Chin Integr Med. 2007;5:546e554.
[41] Tominaga A, Ishizaki N, Naruse Y, Kitakoji H, Yamamura Y.
Repeated application of low-frequency electroacupuncture
improves high-fructose diet-induced insulin resistance in rats.
Acupunct Med. 2011;29:276e283.
